Biology and Clinical Relevance of EpCAM

Overview

Journal Cell Stress

Date 2019 Jun 22

PMID 31225512

Citations 79

Authors

Laura Keller

Stefan Werner

Klaus Pantel

Affiliations

Soon will be listed here.

Abstract

Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker.

Citing Articles

Biological roles and clinical applications of EpCAM in HCC.

Liu P, Zhang Q, Liu F Discov Oncol. 2025; 16(1):319.

PMID: 40087210 DOI: 10.1007/s12672-025-02095-0.

Development of an optimized cell-based selection system for phage display libraries.

Czarnecka M, Findik N, Schlor A, Hanack K Biol Methods Protoc. 2025; 10(1):bpaf009.

PMID: 39968222 PMC: 11835232. DOI: 10.1093/biomethods/bpaf009.

Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism.

Bergmann L, Afflerbach A, Yuan T, Pantel K, Smit D Semin Immunopathol. 2025; 47(1):14.

PMID: 39893314 PMC: 11787191. DOI: 10.1007/s00281-025-01042-z.

New insights into Notch signaling as a crucial pathway of pancreatic cancer stem cell behavior by chrysin-polylactic acid-based nanocomposite.

Ragab E, El Gamal D, El-Najjar F, Elkomy H, Ragab M, Elantary M Discov Oncol. 2025; 16(1):107.

PMID: 39891818 PMC: 11787125. DOI: 10.1007/s12672-025-01846-3.

Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting restorative regimens.

Famta P, Shah S, Dey B, Kumar K, Bagasariya D, Vambhurkar G Cancer Pathog Ther. 2025; 3(1):30-47.

PMID: 39872366 PMC: 11764040. DOI: 10.1016/j.cpt.2024.01.001.

References

de Boer C, van Krieken J, Litvinov S . Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol. 1999; 188(2):201-6. DOI: 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8. View

Brown M, Ye J, Rawson R, Goldstein J . Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell. 2000; 100(4):391-8. DOI: 10.1016/s0092-8674(00)80675-3. View

Trebak M, Begg G, Chong J, Kanazireva E, Herlyn D, Speicher D . Oligomeric state of the colon carcinoma-associated glycoprotein GA733-2 (Ep-CAM/EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. J Biol Chem. 2000; 276(3):2299-309. DOI: 10.1074/jbc.M004770200. View

Gires O, Kieu C, FIX P, Schmitt B, Munz M, Wollenberg B . Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule. Cancer. 2001; 92(3):620-8. DOI: 10.1002/1097-0142(20010801)92:3<620::aid-cncr1362>3.0.co;2-f. View

Guillemot J, Naspetti M, Malergue F, Montcourrier P, Galland F, Naquet P . Ep-CAM transfection in thymic epithelial cell lines triggers the formation of dynamic actin-rich protrusions involved in the organization of epithelial cell layers. Histochem Cell Biol. 2001; 116(4):371-8. DOI: 10.1007/s004180100329. View

Abe H, Kuroki M, Imakiire T, Yamauchi Y, Yamada H, Arakawa F . Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients. J Immunol Methods. 2002; 270(2):227-33. DOI: 10.1016/s0022-1759(02)00332-0. View

Nasr A, Nutini M, Palombo B, Guerra E, Alberti S . Mutations of TP53 induce loss of DNA methylation and amplification of the TROP1 gene. Oncogene. 2003; 22(11):1668-77. DOI: 10.1038/sj.onc.1206248. View

Winter M, Nagelkerken B, Mertens A, Rees-Bakker H, Briaire-de Bruijn I, Litvinov S . Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak. Exp Cell Res. 2003; 285(1):50-8. DOI: 10.1016/s0014-4827(02)00045-9. View

Went P, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G . Frequent EpCam protein expression in human carcinomas. Hum Pathol. 2004; 35(1):122-8. DOI: 10.1016/j.humpath.2003.08.026. View

10.

Kopan R, Ilagan M . Gamma-secretase: proteasome of the membrane?. Nat Rev Mol Cell Biol. 2004; 5(6):499-504. DOI: 10.1038/nrm1406. View

11.

McLaughlin P, Trzpis M, Kroesen B, Helfrich W, Terpstra P, Dokter W . Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines. Cancer Gene Ther. 2004; 11(9):603-12. DOI: 10.1038/sj.cgt.7700725. View

12.

Osta W, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun Y . EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res. 2004; 64(16):5818-24. DOI: 10.1158/0008-5472.CAN-04-0754. View

13.

Wolfe M, Kopan R . Intramembrane proteolysis: theme and variations. Science. 2004; 305(5687):1119-23. DOI: 10.1126/science.1096187. View

14.

Rao C, Chianese D, Doyle G, Miller M, Russell T, Sanders Jr R . Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005; 27(1):49-57. View

15.

Ladwein M, Pape U, Schmidt D, Schnolzer M, Fiedler S, Langbein L . The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7. Exp Cell Res. 2005; 309(2):345-57. DOI: 10.1016/j.yexcr.2005.06.013. View

16.

Le Naour F, Andre M, Greco C, Billard M, Sordat B, Emile J . Profiling of the tetraspanin web of human colon cancer cells. Mol Cell Proteomics. 2006; 5(5):845-57. DOI: 10.1074/mcp.M500330-MCP200. View

17.

Spizzo G, Gastl G, Obrist P, Fong D, Haun M, Grunewald K . Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett. 2006; 246(1-2):253-61. DOI: 10.1016/j.canlet.2006.03.002. View

18.

Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y . Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol. 2006; 30(1):171-9. View

19.

Baeuerle P, Gires O . EpCAM (CD326) finding its role in cancer. Br J Cancer. 2007; 96(3):417-23. PMC: 2360029. DOI: 10.1038/sj.bjc.6603494. View

20.

Tai K, Shiah S, Shieh Y, Kao Y, Chi C, Huang E . DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene. 2007; 26(27):3989-97. DOI: 10.1038/sj.onc.1210176. View